Author: K-STOCK Editor

[Disclosure] Jusung Engineering(036930) – Decision on Cash/In-Kind Dividend / 2024-01-31

[Disclosure] Jusung Engineering(036930) – Decision on Cash/In-Kind Dividend / 2024-01-31

Semiconductors

[Disclosure] Jusung Engineering(036930) – Resolution on Convening of General Meeting of Shareholders / 2024-01-31

[Disclosure] Jusung Engineering(036930) – Resolution on Convening of General Meeting of Shareholders / 2024-01-31

Semiconductors

[Disclosure] HPSP (403870) – Additional Listing (Exercise of Stock Options) / 2024-01-29

[Disclosure] HPSP (403870) – Additional Listing (Exercise of Stock Options) / 2024-01-29

Semiconductors

[Disclosure] SK hynix (000660 / SKHY) – Decision on Cash and In-Kind Dividend / 2024-01-25

[Disclosure] SK hynix (000660 / SKHY) – Decision on Cash and In-Kind Dividend / 2024-01-25

Disclosures

[Disclosure] SK hynix (000660 / SKHY) – Change in Revenue or Loss/Profit Structure Exceeding 30% (15% for Large Corporations) / 2024-01-25

[Disclosure] SK hynix (000660 / SKHY) – Change in Revenue or Loss/Profit Structure Exceeding 30% (15% for Large Corporations) / 2024-01-25

Disclosures

[Disclosure] SK hynix (000660 / SKHY) – Decision on Disposal of Treasury Shares / 2024-01-25

[Disclosure] SK hynix (000660 / SKHY) – Decision on Disposal of Treasury Shares / 2024-01-25

Disclosures

[Disclosure] SK hynix (000660 / SKHY) – Provisional Operating Results (Fair Disclosure) / 2024-01-25

[Disclosure] SK hynix (000660 / SKHY) – Provisional Operating Results (Fair Disclosure) / 2024-01-25

Disclosures

[Disclosure] Samsung Biologics (207940) – Provisional Performance (Consolidated Financial Results) / 2024-01-24

[Disclosure] Samsung Biologics (207940) – Provisional Performance (Consolidated Financial Results) / 2024-01-24

Disclosures

[Disclosure] Samsung Biologics (207940) – Change in Profit and Loss Structure Exceeding 30% (15% for Large Corporations) / 2024-01-24

[Disclosure] Samsung Biologics (207940) – Change in Profit and Loss Structure Exceeding 30% (15% for Large Corporations) / 2024-01-24

Disclosures

[Disclosure] Samsung Biologics (207940) – Outlook on Business Performance (Consolidated Financial Results) / 2024-01-24

[Disclosure] Samsung Biologics (207940) – Outlook on Business Performance (Consolidated Financial Results) / 2024-01-24

Disclosures